Sentences with phrase «clinical applications of the technology»

The clinical application of this technology is clear, says lead author Emre Ozkumur, a biomedical engineer also at Massachusetts General Hospital who developed the system with Toner.

Sunday, September 25 2:15 - 3:00 pm — The godfather of iPSCs, Nobel Prize - winner Shinya Yamanaka presents the opening keynote address on recent progress made in iPSC research and future clinical applications of the technology.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

As genetic technologies advance both in terms of speed and reducing costs, more and more clinical applications are seen in the NHS.

The new material, described online 25 April in Science by synthetic chemist Andreas Lendlein of mnemoScience GmbH in Aachen, Germany, and biomedical engineer Robert Langer of the Massachusetts Institute of Technology, is composed of two polymers, each already used separately in clinical applications such as drug delivery.

This work represents a first step towards the use of graphene in research as well as clinical neural devices, showing that graphene - based technologies can deliver the high resolution and high SNR needed for these applications.

To strengthen its clinical research profile, Dresden has created a strategic plan, to be funded by the German Research Ministry (BMBF), that focuses on three aspects of clinical research: tissue engineering and development of physical and molecular medical technologies for clinical application; therapeutic strategies after cell and tissue damage; and diagnosis and therapy of malignant diseases.

During the webinar, our expert panel of researchers will discuss: • Strategies and technologies for successful cancer biomarker discovery through robust detection and analysis of miRNAs in biofluids • Research into analytic and biological variables that impact miRNA measurements in serum and plasma from the clinical pathologist's point of view • The novel application of miRNAs in serum as biomarkers of aging and chronic disease • The answers to questions submitted by the live, online viewers.

«The use of a mouse tumor - derived matrix would limit any future applications of these organoid technologies in humans, and this work opens the door to research directed specifically for clinical applications,» noted Asma Nusrat, study co-author and the Aldred Scott Warthin Professor and Director of Experimental Pathology in the University of Michigan's School of Medicine.

The team of biomedical engineers — Rao and Kannan — focus on assessing numerous applications of these probes, including standard biopsy analysis and pushing the technology into clinical practice through the development of a point - of - care cancer detection device.

There are alternatives to centrifugation such as microfluidic technology, which has been widely studied for various applications in biological and chemical analysis, point - of - care testing and diagnostics, and clinical analysis.

Through its effort to develop, produce and distribute a suite of genome RMs, the consortium is providing medical and research laboratories worldwide with the tools they need to advance clinical applications of whole genome sequencing, and the FDA with the ability to conduct science - based regulatory oversight of the technology.

The technology still has a number of regulatory hurdles to overcome before it reaches clinical applications for both applications.

CMIIT's mission is to engage the molecular imaging community and leverage the SNMMI infrastructure to advance the adoption of emerging molecular imaging technologies and probes in preclinical and clinical applications.

The Showe Laboratory will be performing the optimization and validation of the prototype glioblastoma diagnostic test, transferring the assay to a more versatile technology platform that is better suited for clinical applications.

The Visikol technology has applications in the fields of toxicology, pre ‐ clinical drug development, clinical diagnostics, basic research and plant biology and can be particularly valuable in fields like drug development and cancer diagnostics.

Areas of focus include the clinical and health implications of using probiotics, potential forensic uses of microbiome profiles, bioterrorism and biodefense applications, the application of new technologies from the project, and patenting and privacy issues.

Notwithstanding, there are still barriers (scientific, economic, educational, ethical, legal) that need to be overcome prior to the application of pharmacogenomic technologies towards innovative clinical strategies and optimized therapeutic outcomes.

The Channel encompasses the most important developments in medical technology, including technical devices and information technology, digital health, clinical data and applications of technology to address health problems and improve the quality of people's lives.

USC - ICT has built on sophisticated, yet low - cost gaming technologies to develop interactive systems for clinical applications, including a program called Virtual Iraq / Virtual Afghanistan that shows promise for ameliorating symptoms of post-traumatic stress disorder.

As a Web Applications Engineer he contributes extensive experience with relational database technologies such as MySQL, MSSQL and Oracle to the development and design of the Clinical Trials Registry and Internet Stroke Center web aApplications Engineer he contributes extensive experience with relational database technologies such as MySQL, MSSQL and Oracle to the development and design of the Clinical Trials Registry and Internet Stroke Center web applicationsapplications.

«By creating a personalized Patient - on - a-Chip, we can really begin to understand how diseases, medicines, chemicals, and foods affect an individual's health,» said Geraldine A. Hamilton, PhD, president and chief scientific officer of Emulate, Inc. «The goal of Emulate working with Cedars - Sinai is to advance and qualify the system for new clinical applications and ultimately democratize the technology so that it can have a broad impact on patient healthcare.»

Improvements in computer memory can be expected to have far - reaching effects on all areas of science and technology, especially by facilitating and extending the application of big data and data science in areas from genomic research to clinical medicine to increasingly general artificial intelligence applications.

Topics covered include embryonic stem cells, pluripotency, germline stem cells, tissue - specific stem cells, stem cell differentiation, epigenetics, stem cell genomics and systems biology, genome reprogramming, cancer stem cells, stem cell niches, stem - cell - based disease models, nuclear transfer technology, bioengineering, drug discovery, in vivo imaging of stem cells, therapeutic applications, regenerative medicine, clinical and translational insights, stem cell research policies, ethical issues, and technical or resource - based innovations.

HERCULES, Calif. — April 14, 2018 — New research showcasing the importance of Bio-Rad's Droplet Digital PCR (ddPCR) technology in clinical applications will be featured in more than 60 presentations at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, April 14 - 18.

In a substudy, review outcomes were also compared across different types of clinical research, based in large part on the designations and definitions derived from a number of sources, including a report by Nathan, 14 the Institute of Medicine, 20 the NIH Director's Panel on Clinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanclinical research, based in large part on the designations and definitions derived from a number of sources, including a report by Nathan, 14 the Institute of Medicine, 20 the NIH Director's Panel on Clinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanClinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanclinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified humanclinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified human tissue.

We aim to enable the passing of the torch from pioneering researchers and developers of genome technologies to first movers in healthcare who are establishing cutting edge standard of care applications of genome technology in every day clinical practice.

Dr. Talkowski directs a genomics research program that explores the consequences of genetic variation on human disease, particularly human developmental and neuropsychiatric disorders, as well as the application of innovations in genomics technology to clinical diagnostics.

Translational medicine is the integrated application of innovative pharmacology tools, biomarkers, clinical methods, clinical technologies and study designs to improve disease understanding, confidence in human drug targets and increase confidence in drug candidates, understand the therapeutic index in humans, enhance cost - effective decision making in exploratory development and increase phase II success.

Despite these many hurdles and the newness of the technology, there are already some glimmers of hope for clinical applications of hiPSCs.

Nanopore sequencing, a novel genomics technology, has potential applications for routine biosurveillance, clinical diagnosis, and outbreak investigation of virus infections.

Lipotype offers high quality lipid analysis services with its Lipotype Shotgun Lipidomics Technology for a wide range of customers and applications including biomarker identification for clinical researchers, pharma and biotech companies, functional food development for the food industry, claim support for the cosmetics industry, as well as for the small - scale profiling needs of academic researchers.

Anti-aging medicine is a clinical specialty is founded on the application of advanced scientific and medical technologies for the early detection, prevention, treatment, and reversal of age - related dysfunction, disorders, and diseases.

His clinical interests include arthroscopy, total joint arthroplasty, biological approach to joint surgery, minimally invasive fracture treatment, and application of novel research discoveries (such as stem cell and regenerative medicine technologies) to clinical patients.

The use and study of information technology in its application to law have a natural resonance with the techniques and objectives of clinical education.

They seek our assistance with a wide variety of technology and business - process outsourcing transactions, including the outsourcing of information technology infrastructure and managed services, application development and maintenance, telecommunications services, financial services, transactional processing, and clinical management services.

DIRECTOR OF R&D I have over 15 years of success in Director of R&D roles and a track record of commercializing technologies for medical device, therapeutic, drug delivery, diagnostic, and clinical applications through NIH, DoD, and DoE grants, peer review process, industry collaborations, licenses, and start - upOF R&D I have over 15 years of success in Director of R&D roles and a track record of commercializing technologies for medical device, therapeutic, drug delivery, diagnostic, and clinical applications through NIH, DoD, and DoE grants, peer review process, industry collaborations, licenses, and start - upof success in Director of R&D roles and a track record of commercializing technologies for medical device, therapeutic, drug delivery, diagnostic, and clinical applications through NIH, DoD, and DoE grants, peer review process, industry collaborations, licenses, and start - upof R&D roles and a track record of commercializing technologies for medical device, therapeutic, drug delivery, diagnostic, and clinical applications through NIH, DoD, and DoE grants, peer review process, industry collaborations, licenses, and start - upof commercializing technologies for medical device, therapeutic, drug delivery, diagnostic, and clinical applications through NIH, DoD, and DoE grants, peer review process, industry collaborations, licenses, and start - ups.

About Blog Cancer Genomics & Proteomics (CGP) is an international peer - reviewed journal designed to publish rapidly high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer research.

Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine.

35 years Medical Laboratory professional Areas of Expertise * Clinical Applications Technology * Regulatory Guidelines * Information Technology * System Security / Confidentiality * Product Development * Lean Process * Employee Retention * Laboratory Efficiency and Compliance * Needs Analysis & Implementation * Consensus Building & Teaming * Profitability Improvement * Performance Optimization * System Builds * Budgets * Sy...

electronic Health record (ehr) Implementation Specialist Computer Programs and Systems INC. (CPSI) July 2012 - Present Extensive knowledge of EHR system and web - based application software for healthcare technology including Pharmacy Nursing (POC) Physicians (CPOE) Phys Doc Emergency Departments (EDIS) and many Clinical Software Applications within CPSI / Evident.